Maynard Um
-
-
-
-
-
-
-
bioAffinity Technologies Q2 CyPath Lung sales rise over 200% year-over-year
-
-
-
-
-
-
-
bioAffinity Technologies receives Mexico patent allowance for lung cancer test
-
-
-
-
-
-
-
bioAffinity's CyPath Lung test helps avoid biopsy in elderly patient case
-
-
-
-
-
-
-
bioAffinity Technologies raises $1.8 million in registered direct offering
-
-
-
-
-
-
-
bioAffinity Technologies receives China patent for lung cancer diagnostic
-
-
-
-
-
-
-
bioAffinity (BIAF) Increases Efficiency of CyPath Lung Test by Boosting Data Acquisition Throughput by 50% and Reducing Unit Cost
-
-
-
-
-
-
-
bioAffinity (BIAF) Appoints William Bauta as Chief Science Officer
-
451,649 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

